165 related articles for article (PubMed ID: 15745728)
1. Routine human immunodeficiency virus testing: an economic evaluation of current guidelines.
Walensky RP; Weinstein MC; Kimmel AD; Seage GR; Losina E; Sax PE; Zhang H; Smith HE; Freedberg KA; Paltiel AD
Am J Med; 2005 Mar; 118(3):292-300. PubMed ID: 15745728
[TBL] [Abstract][Full Text] [Related]
2. Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
Paltiel AD; Weinstein MC; Kimmel AD; Seage GR; Losina E; Zhang H; Freedberg KA; Walensky RP
N Engl J Med; 2005 Feb; 352(6):586-95. PubMed ID: 15703423
[TBL] [Abstract][Full Text] [Related]
3. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.
Paltiel AD; Walensky RP; Schackman BR; Seage GR; Mercincavage LM; Weinstein MC; Freedberg KA
Ann Intern Med; 2006 Dec; 145(11):797-806. PubMed ID: 17146064
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.
Sanders GD; Bayoumi AM; Sundaram V; Bilir SP; Neukermans CP; Rydzak CE; Douglass LR; Lazzeroni LC; Holodniy M; Owens DK
N Engl J Med; 2005 Feb; 352(6):570-85. PubMed ID: 15703422
[TBL] [Abstract][Full Text] [Related]
5. Who should be screened for HIV infection? A cost-effectiveness analysis.
McCarthy BD; Wong JB; Muñoz A; Sonnenberg FA
Arch Intern Med; 1993 May; 153(9):1107-16. PubMed ID: 8481077
[TBL] [Abstract][Full Text] [Related]
6. Optimal allocation of testing dollars: the example of HIV counseling, testing, and referral.
Walensky RP; Weinstein MC; Smith HE; Freedberg KA; Paltiel AD
Med Decis Making; 2005; 25(3):321-9. PubMed ID: 15951459
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection.
Lurie P; Avins AL; Phillips KA; Kahn JG; Lowe RA; Ciccarone D
JAMA; 1994 Dec; 272(23):1832-8. PubMed ID: 7990217
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department.
Dowdy DW; Rodriguez RM; Hare CB; Kaplan B
Acad Emerg Med; 2011 Jul; 18(7):745-53. PubMed ID: 21762236
[TBL] [Abstract][Full Text] [Related]
9. The lifetime cost of current human immunodeficiency virus care in the United States.
Schackman BR; Gebo KA; Walensky RP; Losina E; Muccio T; Sax PE; Weinstein MC; Seage GR; Moore RD; Freedberg KA
Med Care; 2006 Nov; 44(11):990-7. PubMed ID: 17063130
[TBL] [Abstract][Full Text] [Related]
10. Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis.
Sax PE; Islam R; Walensky RP; Losina E; Weinstein MC; Goldie SJ; Sadownik SN; Freedberg KA
Clin Infect Dis; 2005 Nov; 41(9):1316-23. PubMed ID: 16206108
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial.
Schackman BR; Metsch LR; Colfax GN; Leff JA; Wong A; Scott CA; Feaster DJ; Gooden L; Matheson T; Haynes LF; Paltiel AD; Walensky RP
Drug Alcohol Depend; 2013 Feb; 128(1-2):90-7. PubMed ID: 22971593
[TBL] [Abstract][Full Text] [Related]
12. Screening for proteinuria in US adults: a cost-effectiveness analysis.
Boulware LE; Jaar BG; Tarver-Carr ME; Brancati FL; Powe NR
JAMA; 2003 Dec; 290(23):3101-14. PubMed ID: 14679273
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of Community-based Human Immunodeficiency Virus Self-Testing in Blantyre, Malawi.
Maheswaran H; Clarke A; MacPherson P; Kumwenda F; Lalloo DG; Corbett EL; Petrou S
Clin Infect Dis; 2018 Apr; 66(8):1211-1221. PubMed ID: 29136117
[TBL] [Abstract][Full Text] [Related]
14. HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis.
Long EF
PLoS One; 2011; 6(11):e27625. PubMed ID: 22110698
[TBL] [Abstract][Full Text] [Related]
15. How much should we pay for a new HIV diagnosis? A mathematical model of HIV screening in US clinical settings.
Farnham PG; Sansom SL; Hutchinson AB
Med Decis Making; 2012; 32(3):459-69. PubMed ID: 22247422
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of HIV screening in acute care settings.
Owens DK; Nease RF; Harris RA
Arch Intern Med; 1996 Feb; 156(4):394-404. PubMed ID: 8607724
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
Kim SY; Billah K; Lieu TA; Weinstein MC
Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings.
Hutchinson AB; Patel P; Sansom SL; Farnham PG; Sullivan TJ; Bennett B; Kerndt PR; Bolan RK; Heffelfinger JD; Prabhu VS; Branson BM
PLoS Med; 2010 Sep; 7(9):e1000342. PubMed ID: 20927354
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis.
Cheung K; Roman SA; Wang TS; Walker HD; Sosa JA
J Clin Endocrinol Metab; 2008 Jun; 93(6):2173-80. PubMed ID: 18364376
[TBL] [Abstract][Full Text] [Related]
20. Comparing the costs of HIV screening strategies and technologies in health-care settings.
Farnham PG; Hutchinson AB; Sansom SL; Branson BM
Public Health Rep; 2008; 123 Suppl 3(Suppl 3):51-62. PubMed ID: 19166089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
